Czechia, April 22 -- Czechia based Takeda Pharmaceuticals Czech Republic s.r.o. has secured contract from Fakultni Thomayerova nemocnice for Immunosuppressive agents Drug supplies Medicinal substance vedolizumab ATC L04AG05. The value of the contract is worth 2841651800 CZK.
Published by HT Digital Content Services with permission from Pivotal Sources....